Page last updated: 2024-10-23

astemizole and Contact Dermatitis

astemizole has been researched along with Contact Dermatitis in 2 studies

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Research Excerpts

ExcerptRelevanceReference
"Astemizole is an H1-histamine receptor antagonist with a long duration of action permitting once daily administration."2.37Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. ( Avery, GS; Brogden, RN; Heel, RC; Richards, DM; Speight, TM, 1984)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Richards, DM1
Brogden, RN1
Heel, RC1
Speight, TM1
Avery, GS1
Humphreys, F1
Hunter, JA1

Reviews

1 review available for astemizole and Contact Dermatitis

ArticleYear
Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy.
    Drugs, 1984, Volume: 28, Issue:1

    Topics: Animals; Astemizole; Benzimidazoles; Conjunctivitis; Dermatitis, Contact; Histamine H1 Antagonists;

1984

Trials

1 trial available for astemizole and Contact Dermatitis

ArticleYear
The effects of astemizole, cetirizine and loratadine on the time course of weal and flare reactions to histamine, codeine and antigen.
    The British journal of dermatology, 1991, Volume: 125, Issue:4

    Topics: Adult; Animals; Antigens; Astemizole; Cetirizine; Codeine; Cyproheptadine; Dermatitis, Contact; Dust

1991